GADOTERATE MEGLUMINE

GADOTERATE MEGLUMINE was reported 3733 times

GADOTERATE MEGLUMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONTRAST MEDIA TOXICITY 26 0.2047
1 HEAVY METAL INCREASED 4 0.1818
2 NONTHERAPEUTIC AGENT BLOOD POSITIVE 5 0.1786
3 SCAN WITH CONTRAST 3 0.1579
4 NONTHERAPEUTIC AGENT URINE POSITIVE 12 0.1176
5 GADOLINIUM DEPOSITION DISEASE 58 0.1049
6 ABORTION INDUCED COMPLETE 3 0.1034
7 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 8 0.1000
8 ADMINISTRATION SITE THROMBOSIS 1 0.0909
9 THERMOANAESTHESIA 3 0.0811
10 CONGENITAL CEREBELLAR AGENESIS 3 0.0769
11 HYPERINTENSITY IN BRAIN DEEP NUCLEI 6 0.0714
12 BETA GLOBULIN DECREASED 1 0.0667
13 CONTRAST MEDIA DEPOSITION 20 0.0635
14 MUCOSAL IRRITATION 2 0.0606
15 ANAESTHESIA PROCEDURE 1 0.0526
16 ALPHA 2 GLOBULIN DECREASED 1 0.0435
17 BLOOD HEAVY METAL INCREASED 3 0.0429
18 GLOMERULONEPHRITIS CHRONIC 8 0.0426
19 CONTRAST MEDIA REACTION 90 0.0381
20 POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE II 2 0.0370
21 LARYNGEAL DISCOMFORT 22 0.0345
22 ANGIOSCLEROSIS 2 0.0333
23 BACTERIAL TEST 8 0.0268
24 PERIHEPATIC DISCOMFORT 2 0.0230
25 CONTRAST MEDIA ALLERGY 39 0.0213
26 MULTIPLE DRUG HYPERSENSITIVITY 2 0.0208
27 NEPHROGENIC SYSTEMIC FIBROSIS 62 0.0205
28 INCREASED DOSE ADMINISTERED 6 0.0192
29 UROBILINOGEN URINE INCREASED 3 0.0182
30 ANTI-THYROID ANTIBODY POSITIVE 8 0.0175
31 AUTONOMIC FAILURE SYNDROME 1 0.0172
32 LARYNX IRRITATION 4 0.0171
33 PERINEAL DISORDER 2 0.0167
34 MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 3 0.0166
35 BLADDER NECROSIS 1 0.0156
36 EOSINOPENIA 2 0.0152
37 ANAESTHESIA ORAL 1 0.0149
38 LICE INFESTATION 3 0.0143
39 SKIN PRESSURE MARK 3 0.0142
40 AUTOPHONY 1 0.0133
41 CARBOHYDRATE ANTIGEN 27.29 INCREASED 2 0.0133
42 THYROXINE FREE INCREASED 8 0.0125
43 URINARY SEDIMENT PRESENT 8 0.0124
44 SKIN FIBROSIS 6 0.0124
45 AQUAGENIC PRURITUS 1 0.0122
46 OEDEMA MUCOSAL 12 0.0114
47 CAPILLARITIS 3 0.0109
48 SMALL FIBRE NEUROPATHY 8 0.0108
49 RESPIRATORY TRACT OEDEMA 8 0.0108
50 SICCA SYNDROME 2 0.0104
51 METAL POISONING 6 0.0103
52 TYPE I HYPERSENSITIVITY 35 0.0099
53 GRAM STAIN POSITIVE 2 0.0097
54 FUNGAL SEPSIS 8 0.0096
55 RADIATION ASSOCIATED PAIN 2 0.0096
56 RED BLOOD CELLS URINE POSITIVE 9 0.0093
57 SICK LEAVE 2 0.0089
58 HISTAMINE INTOLERANCE 2 0.0088
59 BURNING SENSATION MUCOSAL 3 0.0085
60 MYOSCLEROSIS 3 0.0081
61 AMYLASE ABNORMAL 1 0.0080
62 VANCOMYCIN INFUSION REACTION 3 0.0080
63 TONGUE GEOGRAPHIC 2 0.0079
64 COLITIS COLLAGENOUS 2 0.0079
65 VIBRATORY SENSE INCREASED 2 0.0079
66 SUPERFICIAL VEIN PROMINENCE 2 0.0078
67 THUNDERCLAP HEADACHE 2 0.0076
68 EPIGLOTTIC OEDEMA 2 0.0076
69 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 2 0.0074
70 HYPERTROPHY 4 0.0074
71 ASYMPTOMATIC BACTERIURIA 1 0.0074
72 SKIN HYPERTROPHY 20 0.0071
73 NAIL BED DISORDER 3 0.0070
74 MITOCHONDRIAL CYTOPATHY 3 0.0068
75 MITRAL VALVE THICKENING 2 0.0067
76 THYROID CYST 4 0.0067
77 PRODUCT RESIDUE PRESENT 36 0.0067
78 LARYNGEAL OEDEMA 40 0.0065
79 MUSCLE DISCOMFORT 5 0.0064
80 COLD-STIMULUS HEADACHE 2 0.0063
81 BLADDER IRRITATION 4 0.0062
82 AORTIC VALVE THICKENING 1 0.0062
83 HYPOHIDROSIS 3 0.0060
84 INJECTION SITE COLDNESS 5 0.0059
85 SNEEZING 131 0.0058
86 ASTHMA EXERCISE INDUCED 2 0.0057
87 CHRONIC RESPIRATORY DISEASE 2 0.0057
88 INFERTILITY 8 0.0053
89 CREATINE KINASE INCREASED 4 0.0052
90 HYPERAEMIA 10 0.0051
91 OROPHARYNGEAL SWELLING 5 0.0051
92 USE OF ACCESSORY RESPIRATORY MUSCLES 2 0.0048
93 ORAL PRURITUS 11 0.0048
94 CANDIDA TEST POSITIVE 2 0.0048
95 LIP PRURITUS 4 0.0047
96 PILOERECTION 5 0.0046
97 PULSE ABNORMAL 11 0.0046
98 GINGIVAL DISCOMFORT 3 0.0045
99 TONGUE OEDEMA 17 0.0045
100 ALLERGY TEST POSITIVE 2 0.0044
101 PHARYNGEAL PARAESTHESIA 7 0.0044
102 MUSCLE CONTRACTIONS INVOLUNTARY 15 0.0043
103 VEIN DISCOLOURATION 2 0.0043
104 EAR SWELLING 9 0.0042
105 CELL MARKER INCREASED 2 0.0042
106 SKIN DISCOMFORT 11 0.0041
107 MUCOSAL DISORDER 4 0.0040
108 URTICARIA 659 0.0039
109 CONJUNCTIVAL OEDEMA 4 0.0039
110 B-CELL APLASIA 1 0.0039
111 AIRWAY COMPLICATION OF ANAESTHESIA 1 0.0038
112 VOMITING PROJECTILE 11 0.0038
113 PUSTULE 9 0.0038
114 JOINT CONTRACTURE 4 0.0037
115 THROAT IRRITATION 164 0.0037
116 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 3 0.0036
117 SKIN TIGHTNESS 17 0.0036
118 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 2 0.0036
119 THROAT TIGHTNESS 96 0.0035
120 SOFT TISSUE SWELLING 2 0.0035
121 BURNOUT SYNDROME 2 0.0035
122 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
123 HILAR LYMPHADENOPATHY 3 0.0034
124 SKIN INDURATION 7 0.0034
125 MONOCYTE COUNT DECREASED 4 0.0033
126 PHARYNGEAL SWELLING 32 0.0033
127 BLOOD PRESSURE IMMEASURABLE 5 0.0033
128 EYE OEDEMA 8 0.0033
129 PHARYNGEAL HYPOAESTHESIA 3 0.0032
130 SKIN TEST POSITIVE 3 0.0032
131 EYELID OEDEMA 37 0.0032
132 PRODUCT USED FOR UNKNOWN INDICATION 4 0.0032
133 OEDEMA GENITAL 2 0.0031
134 MITRAL VALVE CALCIFICATION 2 0.0031
135 LIP OEDEMA 13 0.0031
136 URINE ANALYSIS ABNORMAL 9 0.0030
137 COMPULSIONS 2 0.0030
138 CARDIAC DISCOMFORT 6 0.0030
139 FOAMING AT MOUTH 6 0.0030
140 SENSATION OF FOREIGN BODY 25 0.0030
141 ACQUIRED OESOPHAGEAL WEB 1 0.0029
142 DYSAESTHESIA 9 0.0029
143 BASAL GANGLIA INFARCTION 1 0.0029
144 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
145 CONTRAINDICATED DRUG ADMINISTERED 2 0.0029
146 ANOXIA 1 0.0028
147 GLASSY EYES 2 0.0028
148 BREAST CYST 5 0.0028
149 BRONCHOSPASM 40 0.0028
150 AORTIC VALVE SCLEROSIS 2 0.0027
151 MUSCLE TWITCHING 62 0.0027
152 RASH MACULO-PAPULAR 59 0.0026
153 ANISOCORIA 1 0.0026
154 CARBOHYDRATE ANTIGEN 15-3 INCREASED 2 0.0026
155 AMYOTROPHY 1 0.0026
156 PARAESTHESIA ORAL 37 0.0026
157 TYPE IV HYPERSENSITIVITY REACTION 7 0.0026
158 SWELLING OF EYELID 16 0.0025
159 JOINT NOISE 5 0.0025
160 LIP ERYTHEMA 2 0.0025
161 FACE OEDEMA 42 0.0025
162 TUMOUR EXCISION 2 0.0025
163 INTERVERTEBRAL DISC SPACE NARROWING 2 0.0025
164 MUSCLE CONTRACTURE 5 0.0025
165 CEREBRAL ARTERY EMBOLISM 3 0.0025
166 PSEUDOMONAS TEST POSITIVE 2 0.0024
167 MITOCHONDRIAL TOXICITY 2 0.0024
168 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 2 0.0024
169 ANAPHYLACTOID REACTION 10 0.0024
170 INJECTION RELATED REACTION 4 0.0024
171 GLOMERULAR FILTRATION RATE INCREASED 2 0.0024
172 ILLUSION 4 0.0024
173 BLADDER DISCOMFORT 3 0.0024
174 VASODILATATION 6 0.0024
175 AUTOIMMUNE THYROIDITIS 9 0.0024
176 SUPERFICIAL VEIN THROMBOSIS 2 0.0024
177 LOCALISED OEDEMA 11 0.0024
178 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 14 0.0024
179 TONGUE DISCOMFORT 10 0.0024
180 TONGUE PRURITUS 2 0.0023
181 PAPULE 16 0.0023
182 INDURATION 4 0.0022
183 CONJUNCTIVAL HYPERAEMIA 8 0.0022
184 CATARRH 2 0.0022
185 ALLERGY TO ARTHROPOD STING 1 0.0022
186 LICHENOID KERATOSIS 5 0.0022
187 IMMUNOGLOBULINS DECREASED 3 0.0022
188 FIBROMA 2 0.0022
189 CHRONIC FATIGUE SYNDROME 3 0.0022
190 ADVERSE FOOD REACTION 2 0.0021
191 ANAPHYLACTOID SHOCK 1 0.0021
192 ERYTHEMA 434 0.0021
193 GENERALISED ERYTHEMA 12 0.0021
194 SOLAR LENTIGO 2 0.0021
195 SKIN TEXTURE ABNORMAL 2 0.0021
196 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 3 0.0021
197 EYELID RASH 2 0.0020
198 STRIDOR 6 0.0020
199 ANAPHYLACTIC SHOCK 52 0.0020
200 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
201 OROPHARYNGEAL DISCOMFORT 18 0.0020
202 COLD SWEAT 35 0.0020
203 INTERNATIONAL NORMALISED RATIO DECREASED 8 0.0020
204 GOITRE 8 0.0020
205 EYE SWELLING 71 0.0019
206 LARYNGOSPASM 5 0.0019
207 AMAUROSIS FUGAX 2 0.0019
208 LANGUAGE DISORDER 4 0.0018
209 INFECTION SUSCEPTIBILITY INCREASED 4 0.0018
210 FEELING HOT 111 0.0018
211 ELECTRIC SHOCK SENSATION 5 0.0018
212 ANAPHYLACTIC REACTION 97 0.0018
213 CORTISOL DECREASED 2 0.0017
214 INJECTION SITE OEDEMA 3 0.0017
215 ADMINISTRATION SITE PAIN 2 0.0017
216 OCCUPATIONAL EXPOSURE TO PRODUCT 11 0.0017
217 PROCALCITONIN INCREASED 2 0.0017
218 RECTAL ULCER 2 0.0017
219 EXTRAVASATION 7 0.0017
220 ADRENAL ADENOMA 1 0.0017
221 MEDICATION RESIDUE PRESENT 8 0.0017
222 EOSINOPHILIA 29 0.0017
223 MONOCYTE COUNT INCREASED 6 0.0017
224 ALLERGY TO METALS 1 0.0016
225 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
226 FOOD INTOLERANCE 6 0.0016
227 PHARYNGEAL OEDEMA 25 0.0016
228 RETINAL TEAR 4 0.0016
229 BLOOD UREA DECREASED 2 0.0016
230 ALLERGY TO CHEMICALS 2 0.0016
231 PRODUCT LEAKAGE 9 0.0016
232 BLOOD PARATHYROID HORMONE ABNORMAL 1 0.0016
233 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
234 LYMPHADENOPATHY MEDIASTINAL 3 0.0016
235 ANAL INFLAMMATION 1 0.0016
236 RETCHING 33 0.0015
237 ALLERGIC OEDEMA 1 0.0015
238 PERIORBITAL OEDEMA 8 0.0015
239 TONIC CLONIC MOVEMENTS 2 0.0015
240 FEELING OF BODY TEMPERATURE CHANGE 9 0.0015
241 PULSE ABSENT 7 0.0015
242 SIALOADENITIS 2 0.0015
243 SPINAL PAIN 17 0.0014
244 RED BLOOD CELL COUNT INCREASED 4 0.0014
245 RASH MORBILLIFORM 4 0.0014
246 SUDDEN ONSET OF SLEEP 2 0.0014
247 LIVEDO RETICULARIS 3 0.0014
248 MAST CELL ACTIVATION SYNDROME 2 0.0014
249 PERIPHERAL ARTERY OCCLUSION 2 0.0014
250 SKIN REACTION 20 0.0014
251 LIP SWELLING 47 0.0014
252 CYANOSIS 22 0.0014
253 HYPERVENTILATION 8 0.0014
254 RASH PUSTULAR 10 0.0014
255 ACCOMMODATION DISORDER 1 0.0014
256 SENSORY LOSS 11 0.0014
257 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
258 PRECANCEROUS SKIN LESION 2 0.0014
259 PARESIS 3 0.0013
260 MENTAL FATIGUE 2 0.0013
261 KOUNIS SYNDROME 3 0.0013
262 BASOPHIL COUNT INCREASED 1 0.0013
263 ASPIRATION PLEURAL CAVITY 1 0.0013
264 FIBROSIS 4 0.0013
265 BURNING SENSATION 91 0.0013
266 NEURITIS 2 0.0013
267 SWELLING FACE 84 0.0013
268 NEOPLASM SKIN 2 0.0013
269 CHEST DISCOMFORT 131 0.0013
270 PRURITUS 491 0.0013
271 CHOKING SENSATION 7 0.0013
272 INTESTINAL OPERATION 2 0.0013
273 LACRIMATION INCREASED 38 0.0013
274 FEELING COLD 35 0.0013
275 PALLOR 34 0.0012
276 DIABETES INSIPIDUS 3 0.0012
277 PERIORBITAL SWELLING 7 0.0012
278 CARDIOVASCULAR INSUFFICIENCY 2 0.0012
279 LYMPHOCYTE COUNT INCREASED 4 0.0012
280 EXERCISE TOLERANCE DECREASED 7 0.0012
281 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
282 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0012
283 ADRENAL MASS 1 0.0012
284 RESPIRATORY DISTRESS 33 0.0012
285 DISTURBANCE IN ATTENTION 64 0.0012
286 SEIZURE LIKE PHENOMENA 2 0.0012
287 BLOOD CHLORIDE DECREASED 3 0.0012
288 DYSPHONIA 68 0.0012
289 UNRESPONSIVE TO STIMULI 30 0.0012
290 RESPIRATION ABNORMAL 8 0.0012
291 ACUTE SINUSITIS 2 0.0012
292 BRAIN FOG 18 0.0011
293 ALOPECIA AREATA 2 0.0011
294 PANCREATIC FAILURE 2 0.0011
295 FACIAL PARESIS 4 0.0011
296 HEAD DISCOMFORT 20 0.0011
297 BLOOD ALBUMIN INCREASED 1 0.0011
298 OCULAR HYPERAEMIA 53 0.0011
299 PRESYNCOPE 27 0.0011
300 ERYTHEMA OF EYELID 6 0.0011
301 SKIN WRINKLING 3 0.0011
302 CLUMSINESS 3 0.0011
303 PARAESTHESIA 171 0.0011
304 BODY TEMPERATURE ABNORMAL 2 0.0011
305 MOTOR DYSFUNCTION 11 0.0011
306 HEPATITIS ACUTE 7 0.0011
307 COUGH 302 0.0011
308 ERYTHEMA MULTIFORME 10 0.0011
309 NASAL CONGESTION 63 0.0011
310 ANGIOPATHY 6 0.0011
311 ACUTE PULMONARY OEDEMA 6 0.0011
312 TUNNEL VISION 2 0.0011
313 SKIN PLAQUE 9 0.0011
314 FLANK PAIN 10 0.0011
315 NASAL OBSTRUCTION 2 0.0011
316 STENOSIS 2 0.0011
317 HYPOAESTHESIA ORAL 16 0.0011
318 INJECTION SITE EXTRAVASATION 13 0.0011
319 NEUROLOGICAL SYMPTOM 6 0.0010
320 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 27 0.0010
321 GINGIVAL RECESSION 2 0.0010
322 RENAL PAIN 11 0.0010
323 CARCINOEMBRYONIC ANTIGEN INCREASED 2 0.0010
324 CONVERSION DISORDER 2 0.0010
325 HORMONE LEVEL ABNORMAL 5 0.0010
326 STRABISMUS 3 0.0010
327 DROOLING 7 0.0010
328 CREPITATIONS 3 0.0010
329 VEIN DISORDER 5 0.0010
330 SENSORY DISTURBANCE 16 0.0010
331 HYPOPHYSITIS 2 0.0010
332 SINUS TACHYCARDIA 14 0.0010
333 DYSPNOEA 556 0.0010
334 EYE PRURITUS 33 0.0010
335 HYPERAESTHESIA 8 0.0010
336 DIASTOLIC DYSFUNCTION 3 0.0010
337 TONGUE BITING 2 0.0010
338 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
339 SWOLLEN TONGUE 30 0.0010
340 BLOOD CREATININE DECREASED 3 0.0010
341 BLAST CELL COUNT INCREASED 1 0.0010
342 GINGIVAL BLEEDING 13 0.0010
343 OXYGEN SATURATION DECREASED 53 0.0009
344 POOR PERIPHERAL CIRCULATION 4 0.0009
345 TENSION HEADACHE 4 0.0009
346 EXOPHTHALMOS 2 0.0009
347 MUSCLE TIGHTNESS 15 0.0009
348 FLUSHING 93 0.0009
349 ACCIDENT AT WORK 2 0.0009
350 VOMITING 423 0.0009
351 APHASIA 27 0.0009
352 BONE PAIN 52 0.0009
353 DRY THROAT 9 0.0009
354 HEPATIC CYST 3 0.0009
355 BLOOD ALBUMIN DECREASED 7 0.0009
356 METASTASES TO MENINGES 2 0.0009
357 SKIN ATROPHY 5 0.0009
358 EYELID DISORDER 2 0.0009
359 HAEMANGIOMA 2 0.0009
360 NEURALGIA 21 0.0009
361 EXTRASYSTOLES 6 0.0009
362 ANGIOEDEMA 38 0.0009
363 ALLODYNIA 1 0.0009
364 EAR PRURITUS 3 0.0009
365 TINNITUS 39 0.0008
366 ACUTE CORONARY SYNDROME 7 0.0008
367 FIBRIN D DIMER INCREASED 3 0.0008
368 URINARY INCONTINENCE 25 0.0008
369 URINARY HESITATION 2 0.0008
370 PRURITUS GENERALISED 18 0.0008
371 DYSPHAGIA 79 0.0008
372 ADVERSE REACTION 11 0.0008
373 PRODUCT USE IN UNAPPROVED INDICATION 205 0.0008
374 WHEEZING 48 0.0008
375 TACHYPNOEA 11 0.0008
376 HYPERACUSIS 3 0.0008
377 NEURODERMATITIS 3 0.0008
378 TACHYARRHYTHMIA 2 0.0008
379 EYELID IRRITATION 2 0.0008
380 PROTEIN TOTAL DECREASED 3 0.0008
381 IMPAIRED WORK ABILITY 17 0.0008
382 TENDON PAIN 6 0.0008
383 COORDINATION ABNORMAL 11 0.0008
384 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
385 AMMONIA INCREASED 4 0.0008
386 THYROID MASS 3 0.0008
387 EAR DISCOMFORT 8 0.0008
388 MEAN CELL VOLUME INCREASED 2 0.0008
389 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
390 RASH MACULAR 27 0.0008
391 LIPOMA 2 0.0008
392 SKIN ODOUR ABNORMAL 3 0.0008
393 INCONTINENCE 8 0.0008
394 NASAL DISCOMFORT 6 0.0008
395 RASH ERYTHEMATOUS 36 0.0008
396 ANION GAP INCREASED 1 0.0007
397 QUALITY OF LIFE DECREASED 10 0.0007
398 WEIGHT BEARING DIFFICULTY 2 0.0007
399 BRADYPNOEA 2 0.0007
400 EYE MOVEMENT DISORDER 5 0.0007
401 HYPOMENORRHOEA 2 0.0007
402 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
403 MACULE 2 0.0007
404 BLOOD UREA INCREASED 12 0.0007
405 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
406 MUSCLE FATIGUE 3 0.0007
407 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
408 HAEMATOCRIT DECREASED 14 0.0007
409 AUDITORY DISORDER 1 0.0007
410 HYPOTONIA 7 0.0007
411 SALIVARY HYPERSECRETION 7 0.0007
412 SLEEP DISORDER 49 0.0007
413 DERMATITIS BULLOUS 5 0.0007
414 MONOPLEGIA 3 0.0007
415 TASTE DISORDER 14 0.0007
416 NAUSEA 539 0.0007
417 TOOTH DISCOLOURATION 2 0.0007
418 FACIAL PAIN 6 0.0007
419 LOSS OF CONSCIOUSNESS 85 0.0007
420 PAROSMIA 5 0.0007
421 LOSS OF EMPLOYMENT 2 0.0007
422 HYPOAESTHESIA 99 0.0007
423 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
424 URINE ABNORMALITY 3 0.0007
425 HYPERHIDROSIS 85 0.0007
426 EMBOLISM VENOUS 2 0.0007
427 PERIPHERAL COLDNESS 9 0.0007
428 ISCHAEMIA 3 0.0007
429 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
430 JOINT STIFFNESS 17 0.0006
431 ORAL DISCOMFORT 9 0.0006
432 PERFORMANCE STATUS DECREASED 3 0.0006
433 RESPIRATORY RATE DECREASED 2 0.0006
434 DERMATITIS ALLERGIC 8 0.0006
435 SKIN ABRASION 3 0.0006
436 COLITIS MICROSCOPIC 3 0.0006
437 PRE-ECLAMPSIA 3 0.0006
438 CHILLS 74 0.0006
439 BLADDER PAIN 2 0.0006
440 TRANSAMINASES INCREASED 14 0.0006
441 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
442 HYPERTENSIVE CRISIS 7 0.0006
443 PARALYSIS 9 0.0006
444 SYRINGE ISSUE 11 0.0006
445 RESTLESSNESS 23 0.0006
446 ORTHOPNOEA 2 0.0006
447 IMPAIRED QUALITY OF LIFE 9 0.0006
448 VULVOVAGINAL DRYNESS 2 0.0006
449 MYALGIA 105 0.0006
450 RASH 269 0.0006
451 LIVER ABSCESS 2 0.0006
452 FACET JOINT SYNDROME 2 0.0006
453 HYPOVENTILATION 2 0.0006
454 HYPERSENSITIVITY 113 0.0006
455 EYE IRRITATION 35 0.0006
456 ANTIBODY TEST POSITIVE 1 0.0006
457 PROTEIN URINE PRESENT 3 0.0006
458 DERMATITIS EXFOLIATIVE 3 0.0006
459 SKIN MASS 4 0.0006
460 CYTOKINE RELEASE SYNDROME 12 0.0006
461 TREMOR 98 0.0006
462 CIRCULATORY COLLAPSE 10 0.0006
463 BLOOD PRESSURE DECREASED 39 0.0006
464 PHLEBITIS 3 0.0006
465 POLYNEUROPATHY 7 0.0006
466 BLOOD SODIUM DECREASED 11 0.0006
467 TEMPERATURE INTOLERANCE 6 0.0006
468 ANURIA 5 0.0006
469 FAILURE TO THRIVE 3 0.0006
470 MICTURITION DISORDER 2 0.0006
471 HYPOPNOEA 2 0.0006
472 FORMICATION 4 0.0006
473 TACHYCARDIA 51 0.0006
474 MUSCULAR WEAKNESS 65 0.0006
475 MENORRHAGIA 11 0.0006
476 HAEMATURIA 19 0.0006
477 BONE LESION 2 0.0006
478 VISUAL FIELD DEFECT 4 0.0006
479 HYPERTHYROIDISM 8 0.0006
480 MUSCLE ATROPHY 7 0.0006
481 CUTANEOUS VASCULITIS 2 0.0005
482 ASTHMATIC CRISIS 2 0.0005
483 HYPOPHOSPHATAEMIA 4 0.0005
484 CONJUNCTIVITIS 10 0.0005
485 OCULAR DISCOMFORT 6 0.0005
486 ABORTION INDUCED 5 0.0005
487 SKIN BURNING SENSATION 38 0.0005
488 HAEMODYNAMIC INSTABILITY 4 0.0005
489 HYPOTENSION 105 0.0005
490 MOUTH SWELLING 3 0.0005
491 METABOLIC DISORDER 3 0.0005
492 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
493 BODY TEMPERATURE DECREASED 5 0.0005
494 OESOPHAGEAL PAIN 2 0.0005
495 RESPIRATORY TRACT CONGESTION 8 0.0005
496 ODYNOPHAGIA 3 0.0005
497 ANORECTAL DISORDER 1 0.0005
498 ENURESIS 2 0.0005
499 RESTLESS LEGS SYNDROME 9 0.0005
500 LYMPHOPENIA 7 0.0005
501 HEART RATE INCREASED 49 0.0005
502 MUSCLE DISORDER 4 0.0005
503 HYPOTHERMIA 5 0.0005
504 TENSION 3 0.0005
505 RASH PAPULAR 11 0.0005
506 ASPHYXIA 4 0.0005
507 ABNORMAL FAECES 4 0.0005
508 INFUSION SITE EXTRAVASATION 3 0.0005
509 PETECHIAE 5 0.0005
510 CARDIO-RESPIRATORY ARREST 20 0.0005
511 BLEPHAROSPASM 3 0.0005
512 VISUAL IMPAIRMENT 59 0.0005
513 PHOTOPSIA 3 0.0005
514 PROTEINURIA 9 0.0005
515 HEPATIC CYTOLYSIS 6 0.0005
516 FACIAL PARALYSIS 4 0.0005
517 SEIZURE 54 0.0005
518 HAEMOPTYSIS 13 0.0005
519 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
520 BLISTER 26 0.0005
521 DRY EYE 23 0.0005
522 BRADYPHRENIA 3 0.0005
523 TONGUE DISCOLOURATION 2 0.0005
524 IMMUNE SYSTEM DISORDER 6 0.0005
525 PHYSICAL DISABILITY 2 0.0005
526 BLOOD CREATINE INCREASED 2 0.0005
527 DYSPNOEA EXERTIONAL 17 0.0005
528 NECK PAIN 25 0.0004
529 RASH PRURITIC 24 0.0004
530 PRODUCT LABEL ISSUE 3 0.0004
531 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
532 MICTURITION URGENCY 5 0.0004
533 LYMPHOEDEMA 3 0.0004
534 CARDIOVASCULAR DISORDER 11 0.0004
535 DIZZINESS 216 0.0004
536 METASTASES TO LUNG 5 0.0004
537 HYPERTRANSAMINASAEMIA 3 0.0004
538 SYNCOPE 43 0.0004
539 ROSACEA 2 0.0004
540 YELLOW SKIN 2 0.0004
541 VERTIGO 26 0.0004
542 RASH GENERALISED 11 0.0004
543 HAEMATOMA 11 0.0004
544 DIPLOPIA 11 0.0004
545 DRUG LEVEL INCREASED 7 0.0004
546 NEUTROPENIC SEPSIS 3 0.0004
547 DYSGEUSIA 31 0.0004
548 PANIC REACTION 3 0.0004
549 HYPERCHOLESTEROLAEMIA 4 0.0004
550 RASH VESICULAR 2 0.0004
551 SKIN DISCOLOURATION 19 0.0004
552 APATHY 6 0.0004
553 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
554 EYE PAIN 23 0.0004
555 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
556 BREATH SOUNDS ABNORMAL 2 0.0004
557 ABDOMINAL TENDERNESS 2 0.0004
558 SKIN LESION 11 0.0004
559 MUSCULOSKELETAL STIFFNESS 35 0.0004
560 HEART RATE IRREGULAR 9 0.0004
561 TOXIC SKIN ERUPTION 4 0.0004
562 LYMPHADENOPATHY 14 0.0004
563 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
564 TOXIC ENCEPHALOPATHY 2 0.0004
565 HYPERTHERMIA 3 0.0004
566 SHOCK 9 0.0004
567 INFUSION SITE PAIN 5 0.0004
568 MUSCULOSKELETAL CHEST PAIN 6 0.0004
569 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
570 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
571 TRISMUS 2 0.0004
572 OEDEMA 21 0.0004
573 TOOTHACHE 7 0.0004
574 BLOOD PRESSURE INCREASED 59 0.0004
575 COGNITIVE DISORDER 18 0.0004
576 BLOOD LACTIC ACID INCREASED 2 0.0004
577 TRICUSPID VALVE INCOMPETENCE 3 0.0004
578 AGRANULOCYTOSIS 7 0.0004
579 BLOOD PRESSURE FLUCTUATION 9 0.0004
580 ABDOMINAL MASS 1 0.0004
581 JOINT RANGE OF MOTION DECREASED 5 0.0004
582 ANAESTHETIC COMPLICATION 1 0.0004
583 PHOTOPHOBIA 7 0.0004
584 RHINITIS 3 0.0004
585 PAIN OF SKIN 10 0.0004
586 RHINORRHOEA 24 0.0004
587 FIBROMYALGIA 9 0.0004
588 ABDOMINAL RIGIDITY 1 0.0004
589 PALPITATIONS 43 0.0004
590 ACUTE RESPIRATORY FAILURE 7 0.0004
591 ASTHENOPIA 2 0.0004
592 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
593 PNEUMONIA ASPIRATION 9 0.0004
594 ARRHYTHMIA 17 0.0004
595 VISION BLURRED 49 0.0004
596 PANIC ATTACK 13 0.0004
597 BLOOD CALCIUM DECREASED 4 0.0004
598 LIMB DISCOMFORT 11 0.0004
599 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
600 SWELLING 33 0.0004
601 CHEST PAIN 65 0.0004
602 SKIN HYPERPIGMENTATION 3 0.0003
603 RALES 2 0.0003
604 BLOOD CALCIUM INCREASED 3 0.0003
605 SPINAL OSTEOARTHRITIS 3 0.0003
606 HEADACHE 213 0.0003
607 RESPIRATORY RATE INCREASED 3 0.0003
608 PROTHROMBIN TIME PROLONGED 2 0.0003
609 ANAL INCONTINENCE 3 0.0003
610 HOT FLUSH 25 0.0003
611 SKIN DISORDER 11 0.0003
612 PIGMENTATION DISORDER 2 0.0003
613 HEPATIC ENCEPHALOPATHY 3 0.0003
614 MOOD SWINGS 10 0.0003
615 MOVEMENT DISORDER 10 0.0003
616 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
617 INCOHERENT 2 0.0003
618 LACTIC ACIDOSIS 10 0.0003
619 EAR PAIN 6 0.0003
620 DRY MOUTH 25 0.0003
621 THROMBOTIC MICROANGIOPATHY 3 0.0003
622 PLATELET COUNT INCREASED 4 0.0003
623 RENAL TUBULAR NECROSIS 3 0.0003
624 HEPATOMEGALY 3 0.0003
625 CHOLELITHIASIS 10 0.0003
626 CORONAVIRUS INFECTION 2 0.0003
627 MUSCLE SPASMS 55 0.0003
628 ANXIETY DISORDER 1 0.0003
629 MENSTRUATION IRREGULAR 8 0.0003
630 METASTASES TO LYMPH NODES 2 0.0003
631 SINUS CONGESTION 4 0.0003
632 WRONG PRODUCT ADMINISTERED 2 0.0003
633 HEMIPARESIS 5 0.0003
634 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
635 NEUTROPHIL COUNT INCREASED 3 0.0003
636 FEELING ABNORMAL 70 0.0003
637 BLOOD CREATININE INCREASED 19 0.0003
638 CARDIAC ARREST 24 0.0003
639 NERVOUS SYSTEM DISORDER 9 0.0003
640 SPEECH DISORDER 15 0.0003
641 DEFAECATION URGENCY 2 0.0003
642 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
643 LYMPHOCYTE COUNT DECREASED 5 0.0003
644 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
645 DRUG ERUPTION 5 0.0003
646 THERMAL BURN 2 0.0003
647 HYPOTHYROIDISM 9 0.0003
648 TONGUE DISORDER 2 0.0003
649 SKIN LACERATION 3 0.0003
650 HYPOKINESIA 4 0.0003
651 WOUND INFECTION 3 0.0003
652 ARTHRALGIA 113 0.0003
653 ABDOMINAL PAIN 63 0.0003
654 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
655 SUNBURN 2 0.0003
656 NEPHROPATHY TOXIC 3 0.0003
657 BALANCE DISORDER 23 0.0003
658 EPILEPSY 8 0.0003
659 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
660 RENAL FAILURE CHRONIC 2 0.0003
661 VASCULITIS 3 0.0003
662 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
663 PULMONARY HAEMORRHAGE 2 0.0003
664 MENTAL DISORDER 11 0.0003
665 RENAL CYST 2 0.0003
666 BLOOD PRESSURE ABNORMAL 5 0.0003
667 BLEPHARITIS 1 0.0002
668 C-REACTIVE PROTEIN INCREASED 9 0.0002
669 NOCTURIA 3 0.0002
670 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
671 PAIN IN JAW 7 0.0002
672 OEDEMA PERIPHERAL 30 0.0002
673 DECUBITUS ULCER 2 0.0002
674 BRADYCARDIA 13 0.0002
675 DYSURIA 9 0.0002
676 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
677 ACUTE KIDNEY INJURY 37 0.0002
678 MALAISE 106 0.0002
679 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
680 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
681 HYPERTENSION 51 0.0002
682 HEMIPLEGIA 2 0.0002
683 EOSINOPHIL COUNT INCREASED 2 0.0002
684 SECRETION DISCHARGE 3 0.0002
685 DYSARTHRIA 9 0.0002
686 ABSCESS LIMB 1 0.0002
687 RESPIRATORY DISORDER 7 0.0002
688 VITAMIN D DECREASED 2 0.0002
689 ABNORMAL SENSATION IN EYE 1 0.0002
690 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
691 MUSCULOSKELETAL DISCOMFORT 4 0.0002
692 SKIN SWELLING 2 0.0002
693 DEAFNESS 6 0.0002
694 HEART RATE DECREASED 8 0.0002
695 HYPOXIA 8 0.0002
696 DISORIENTATION 9 0.0002
697 LUNG INFILTRATION 2 0.0002
698 WRONG DRUG ADMINISTERED 2 0.0002
699 THIRST 4 0.0002
700 HEAVY MENSTRUAL BLEEDING 2 0.0002
701 NEUTROPHIL COUNT DECREASED 9 0.0002
702 MEMORY IMPAIRMENT 30 0.0002
703 POLLAKIURIA 9 0.0002
704 AMNESIA 14 0.0002
705 APHONIA 3 0.0002
706 HEPATIC STEATOSIS 4 0.0002
707 SKIN EXFOLIATION 18 0.0002
708 ARTERIOSCLEROSIS 2 0.0002
709 HYPOCALCAEMIA 4 0.0002
710 SPINAL DISORDER 2 0.0002
711 ANGINA PECTORIS 6 0.0002
712 MENTAL IMPAIRMENT 5 0.0002
713 DIZZINESS POSTURAL 2 0.0002
714 VITAMIN D DEFICIENCY 2 0.0002
715 CHOKING 4 0.0002
716 VITREOUS FLOATERS 2 0.0002
717 DISABILITY 4 0.0002
718 PULMONARY MASS 3 0.0002
719 ASTHENIA 75 0.0002
720 BRAIN INJURY 2 0.0002
721 PAIN 121 0.0002
722 PAIN IN EXTREMITY 58 0.0002
723 INITIAL INSOMNIA 2 0.0002
724 MOBILITY DECREASED 14 0.0002
725 THYROID DISORDER 3 0.0002
726 INFLAMMATION 10 0.0002
727 GAIT DISTURBANCE 37 0.0002
728 HYPERBILIRUBINAEMIA 2 0.0002
729 BASAL CELL CARCINOMA 3 0.0002
730 LETHARGY 11 0.0002
731 MUSCULOSKELETAL PAIN 10 0.0002
732 NEUROPATHY PERIPHERAL 18 0.0002
733 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
734 PREMATURE DELIVERY 3 0.0002
735 ANORECTAL DISCOMFORT 1 0.0002
736 EATING DISORDER 4 0.0002
737 POOR QUALITY SLEEP 4 0.0002
738 ANAL ABSCESS 1 0.0002
739 DECREASED ACTIVITY 2 0.0002
740 LIMB INJURY 5 0.0002
741 INSOMNIA 49 0.0002
742 OROPHARYNGEAL PAIN 17 0.0002
743 OESOPHAGITIS 2 0.0002
744 METASTASES TO BONE 3 0.0002
745 ASPIRATION 2 0.0002
746 NO ADVERSE EVENT 33 0.0002
747 GASTROINTESTINAL PAIN 2 0.0002
748 RESPIRATORY ARREST 5 0.0002
749 NERVE INJURY 2 0.0002
750 PANCYTOPENIA 10 0.0002
751 MALNUTRITION 2 0.0002
752 ALOPECIA 35 0.0002
753 ASTHMA 20 0.0002
754 MYOCARDIAL ISCHAEMIA 2 0.0002
755 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
756 HYPOKALAEMIA 8 0.0002
757 DYSPEPSIA 17 0.0002
758 LOCAL SWELLING 3 0.0002
759 LIVER FUNCTION TEST ABNORMAL 5 0.0002
760 BLINDNESS 7 0.0002
761 METASTASES TO LIVER 3 0.0002
762 FATIGUE 132 0.0002
763 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
764 ATAXIA 2 0.0002
765 MYOCLONUS 2 0.0002
766 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
767 PELVIC PAIN 3 0.0002
768 BONE DISORDER 3 0.0002
769 RESPIRATORY FAILURE 12 0.0002
770 DISCOMFORT 10 0.0002
771 MUSCLE SPASTICITY 2 0.0002
772 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
773 TENDON RUPTURE 2 0.0002
774 HYPERCALCAEMIA 2 0.0002
775 GENERALISED OEDEMA 2 0.0002
776 CONFUSIONAL STATE 26 0.0002
777 POISONING 2 0.0002
778 BRAIN OEDEMA 2 0.0002
779 ANXIETY 45 0.0002
780 MIGRAINE 15 0.0002
781 ANGINA UNSTABLE 1 0.0002
782 ASPERGILLUS INFECTION 1 0.0002
783 IMPAIRED HEALING 5 0.0002
784 BEDRIDDEN 2 0.0002
785 APPETITE DISORDER 1 0.0002
786 VISUAL ACUITY REDUCED 5 0.0002
787 GAIT INABILITY 5 0.0001
788 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
789 BODY TEMPERATURE INCREASED 3 0.0001
790 PNEUMONITIS 4 0.0001
791 ABNORMAL LOSS OF WEIGHT 1 0.0001
792 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
793 PYREXIA 50 0.0001
794 MEDICATION ERROR 8 0.0001
795 DERMATITIS 3 0.0001
796 PERIPHERAL SWELLING 22 0.0001
797 RED BLOOD CELL COUNT DECREASED 4 0.0001
798 SOMNOLENCE 28 0.0001
799 ACCIDENTAL UNDERDOSE 2 0.0001
800 HYPERGLYCAEMIA 5 0.0001
801 ABDOMINAL DISCOMFORT 23 0.0001
802 DYSSTASIA 4 0.0001
803 BLINDNESS TRANSIENT 1 0.0001
804 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
805 STEVENS-JOHNSON SYNDROME 3 0.0001
806 DRY SKIN 18 0.0001
807 ECZEMA 7 0.0001
808 SKIN IRRITATION 6 0.0001
809 ACIDOSIS 1 0.0001
810 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
811 APHTHOUS ULCER 1 0.0001
812 BLOOD CHOLESTEROL INCREASED 6 0.0001
813 APNOEA 1 0.0001
814 COMA 6 0.0001
815 THROMBOCYTOPENIA 14 0.0001
816 BACK PAIN 29 0.0001
817 ABORTION SPONTANEOUS 5 0.0001
818 FLATULENCE 7 0.0001
819 CEREBRAL INFARCTION 3 0.0001
820 AGITATION 9 0.0001
821 VENTRICULAR TACHYCARDIA 2 0.0001
822 PHOTOSENSITIVITY REACTION 2 0.0001
823 INJECTION SITE PRURITUS 8 0.0001
824 ABDOMINAL PAIN LOWER 3 0.0001
825 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
826 OSTEOARTHRITIS 5 0.0001
827 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
828 NEUTROPENIA 16 0.0001
829 SCAR 2 0.0001
830 BLOOD MAGNESIUM DECREASED 1 0.0001
831 AMENORRHOEA 2 0.0001
832 ISCHAEMIC STROKE 2 0.0001
833 ABDOMINAL PAIN UPPER 23 0.0001
834 PULMONARY OEDEMA 5 0.0001
835 BLOOD BILIRUBIN INCREASED 3 0.0001
836 SYNOVITIS 2 0.0001
837 LEUKOCYTOSIS 2 0.0001
838 CRYING 4 0.0001
839 DEPRESSION 25 0.0001
840 MENTAL STATUS CHANGES 3 0.0001
841 DEEP VEIN THROMBOSIS 7 0.0001
842 THINKING ABNORMAL 2 0.0001
843 HAEMOGLOBIN DECREASED 11 0.0001
844 MIDDLE INSOMNIA 2 0.0001
845 FRACTURE 2 0.0001
846 INFUSION RELATED REACTION 7 0.0001
847 RENAL FAILURE 14 0.0001
848 PRODUCTIVE COUGH 5 0.0001
849 MULTIPLE SCLEROSIS 5 0.0001
850 INJECTION SITE SWELLING 8 0.0001
851 POST PROCEDURAL COMPLICATION 2 0.0001
852 BLOOD GLUCOSE DECREASED 5 0.0001
853 WEIGHT DECREASED 29 0.0001
854 ATELECTASIS 1 0.0001
855 ERUCTATION 2 0.0001
856 ACUTE MYOCARDIAL INFARCTION 3 0.0001
857 ARTHRITIS 8 0.0001
858 SINUS DISORDER 2 0.0001
859 CATARACT 6 0.0001
860 BLADDER DISORDER 1 0.0001
861 PRESCRIBED UNDERDOSE 2 0.0001
862 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
863 CORONARY ARTERY DISEASE 3 0.0001
864 CONDITION AGGRAVATED 30 0.0001
865 PLEURAL EFFUSION 6 0.0001
866 DYSKINESIA 4 0.0001
867 BONE MARROW FAILURE 2 0.0001
868 SUICIDAL IDEATION 9 0.0001
869 INJECTION SITE RASH 3 0.0001
870 EMOTIONAL DISORDER 3 0.0001
871 INFLUENZA LIKE ILLNESS 8 0.0001
872 EXPOSURE DURING PREGNANCY 6 0.0001
873 DEPRESSED MOOD 5 0.0001
874 INJECTION SITE PAIN 29 0.0001
875 CYSTITIS 3 0.0001
876 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
877 PRODUCT DISPENSING ERROR 2 0.0001
878 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
879 BLOOD GLUCOSE FLUCTUATION 1 0.0001
880 EYE DISORDER 3 0.0001
881 FEBRILE NEUTROPENIA 6 0.0001
882 URINARY RETENTION 3 0.0001
883 HEPATOTOXICITY 2 0.0001
884 GLOSSODYNIA 2 0.0001
885 CHROMATURIA 2 0.0001
886 ILLNESS 9 0.0001
887 PERICARDIAL EFFUSION 2 0.0001
888 DELIRIUM 3 0.0001
889 CARDIAC DISORDER 8 0.0001
890 INJURY 6 0.0001
891 BACTERAEMIA 1 0.0001
892 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
893 EMOTIONAL DISTRESS 10 0.0001
894 STOMATITIS 5 0.0001
895 ADRENAL INSUFFICIENCY 1 0.0001
896 DIARRHOEA 53 0.0001
897 LUNG DISORDER 4 0.0001
898 INJECTION SITE URTICARIA 2 0.0001
899 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
900 HAEMATEMESIS 2 0.0001
901 OVERDOSE 17 0.0001
902 ERECTILE DYSFUNCTION 2 0.0001
903 DECREASED APPETITE 18 0.0001
904 SKIN ULCER 2 0.0001
905 NERVOUSNESS 4 0.0001
906 ANHEDONIA 2 0.0001
907 GASTRITIS 2 0.0001
908 CARDIAC FAILURE 6 0.0001
909 FEAR 2 0.0001
910 HEPATIC ENZYME INCREASED 5 0.0001
911 ARTHROPATHY 4 0.0001
912 RENAL IMPAIRMENT 6 0.0001
913 RECTAL HAEMORRHAGE 3 0.0001
914 HYPERSOMNIA 2 0.0001
915 SEPTIC SHOCK 3 0.0001
916 UNDERDOSE 5 0.0001
917 ASCITES 2 0.0001
918 LABORATORY TEST ABNORMAL 2 0.0001
919 LIVER DISORDER 3 0.0001
920 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
921 ABDOMINAL DISTENSION 7 0.0001
922 GASTROINTESTINAL DISORDER 6 0.0001
923 PREMATURE BABY 2 0.0001
924 ADVERSE EVENT 6 0.0001
925 URINARY TRACT INFECTION 11 0.0001
926 RENAL DISORDER 3 0.0001
927 DRUG-INDUCED LIVER INJURY 2 0.0001
928 HEAD INJURY 2 0.0001
929 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
930 ANAEMIA 12 0.0001
931 HYPOGLYCAEMIA 3 0.0001
932 ATRIAL FIBRILLATION 6 0.0001
933 DEHYDRATION 8 0.0001
934 TOXICITY TO VARIOUS AGENTS 10 0.0001
935 JOINT SWELLING 7 0.0001
936 FALL 19 0.0001
937 PANCREATITIS 3 0.0001
938 CEREBRAL HAEMORRHAGE 2 0.0001
939 CONSTIPATION 12 0.0001
940 BLOOD GLUCOSE ABNORMAL 1 0.0001
941 WEIGHT INCREASED 12 0.0001
942 EPISTAXIS 4 0.0001
943 HYPONATRAEMIA 3 0.0001
944 CEREBROVASCULAR ACCIDENT 9 0.0001
945 UNEVALUABLE EVENT 4 0.0001
946 CONTUSION 5 0.0001
947 ABNORMAL BEHAVIOUR 2 0.0001
948 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
949 INJECTION SITE REACTION 3 0.0000
950 PRODUCT USE ISSUE 8 0.0000
951 THERAPY INTERRUPTED 3 0.0000
952 ABASIA 1 0.0000
953 AGEUSIA 1 0.0000
954 HALLUCINATION 3 0.0000
955 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
956 DERMATITIS ATOPIC 2 0.0000
957 BLOOD GLUCOSE INCREASED 7 0.0000
958 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
959 HERPES ZOSTER 2 0.0000
960 IRRITABILITY 2 0.0000
961 BLOOD POTASSIUM DECREASED 1 0.0000
962 SUICIDE ATTEMPT 2 0.0000
963 INJECTION SITE ERYTHEMA 4 0.0000
964 BREAST CANCER 3 0.0000
965 OFF LABEL USE 28 0.0000
966 DRUG INTERACTION 5 0.0000
967 INTENTIONAL OVERDOSE 2 0.0000
968 DRUG INTOLERANCE 3 0.0000
969 PNEUMONIA 10 0.0000
970 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
971 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
972 PLATELET COUNT DECREASED 3 0.0000
973 ACNE 2 0.0000
974 THROMBOSIS 2 0.0000
975 COMPLETED SUICIDE 2 0.0000
976 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
977 MYOCARDIAL INFARCTION 4 0.0000
978 PRODUCT STORAGE ERROR 2 0.0000
979 NASOPHARYNGITIS 4 0.0000
980 INFECTION 3 0.0000
981 AGGRESSION 1 0.0000
982 SEPSIS 2 0.0000
983 COVID-19 3 0.0000
984 DISEASE PROGRESSION 2 0.0000
985 DRUG INEFFECTIVE 22 0.0000
986 PSORIASIS 2 0.0000
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
988 PRODUCT QUALITY ISSUE 2 0.0000
989 PRODUCT DOSE OMISSION ISSUE 3 0.0000
990 DEATH 8 0.0000
991 INCORRECT DOSE ADMINISTERED 2 0.0000